Drugs & Aging promotes optimum drug therapy in older adults through a program of review and original research articles covering aspects of clinical pharmacology and patient management in this important patient population. The Journal includes:  

Leading/current opinion articles providing an overview of contentious or emerging issues.
Definitive reviews of drugs and drug classes and their place in the management of disease.
Therapy in Practice reviews including recommendations for specific clinical situations. 
Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs. 
High quality, well designed original research with a strong link to clinical practice.

Editor (Adis International Limited, Auckland, New Zealand):
David Williamson
Section Editors (Adis International Limited, Auckland, New Zealand):
Martin Chopra
Alison Fitches
Kathy Fraser
Rod McNab
Kate Palmer
Dene Peters
Sue Pochon
Amitabh Prakash
Editorial Board:
R.R. Aparasu, University of Houston, Houston, TX, USA
W.S. Aronow, New York Medical College, Bronx, NY, USA
R.L. Barkin, Rush University, Chicago, IL, USA
J. Belmin, Universite Paris 6, Ivry-sur-Seine, France
G. Crepaldi, Universita di Padova, Padova, Italy
B.J. Cusack, University of Washington, Seattle, WA, USA
J.-M. Dayer, Centre Medical Universitaire, Geneva, Switzerland
A.B. Fleischer Jr, University of Kentucky, Lexington, KY, USA
G.A. Ford, Oxford Academic Health Science Network, Oxford, England
M. Gordon, University of Toronto, Toronto, ON, Canada
D.J. Greenblatt, Tufts University School of Medicine, Boston, MA, USA
J.T. Hanlon, University of Pittsburgh, Pittsburgh, PA, USA
S. Hilmer, Royal North Shore Hospital and the University of Sydney, Sydney, Australia
H.M. Holmes, University of Texas Medical School, Houston, TX, USA
A. Huang, University of Ottawa, Ottawa, ON, Canada
K. Johnell, Karolinska Institutet, Stockholm, Sweden
R. Kawamori, Juntendo University Graduate School of Medicine, Tokyo, Japan
S.R. Kraus, University of Texas Health Science Center, San Antonio, TX, USA
A. Krentz, ProSciento, San Diego, CA, USA
E.J. Kuipers, Erasmus University Medical Center, Rotterdam, The Netherlands
F. Locatelli, Alessandro Manzoni Hospital, Lecco, Italy
H. Lode, Charité Universitätsmedizin Berlin, Berlin, Germany
M.A. Lopez-Olivo, The University of Texas, Houston, TX, USA
M.G. Matera, Second University of Naples, Naples, Italy
B.L. Maughan, Huntsman Cancer Institute, Salt Lake City, UT, USA
D.E. Meier, Icahn School of Medicine at Mount Sinai, New York, NY, USA
S. Monfardini, IRCCS Geriatric Oncology Unit, Fondazione Don Gnocchi, Milan, Italy
A.D. Mooradian, University of Florida College of Medicine, Jacksonville, FL, USA
D. O'Mahony, Cork University Hospital, Cork, Ireland
M. Petrovic, Ghent University Hospital , Ghent, Belgium
J.-Y. Reginster, University of Liege, Liege, Belgium
P. Rochon, University of Toronto, Toronto, ON, Canada
B.J. Sahakian, University of Cambridge, Cambridge, England
N. Scichilone, University of Palermo, Palermo, Italy
R. Stahlmann, Charité Universitätsmedizin, Berlin, Germany
C.G. Swift, King's College School of Medicine , London, England
R.W. Warne, Royal Perth Hospital, Perth, WA, Australia
M.E. Weksler, Weill Cornell Medical College, New York, NY, USA